511
Participants
Start Date
September 30, 2021
Primary Completion Date
August 13, 2024
Study Completion Date
August 13, 2024
NIS793
Concentrate for solution infusion (Liquid in Vial)
Nab-paclitaxel
Per locally approved formulation
Gemcitabine
Per locally approved formulation
Placebo
Dextrose 5% in water (D5W) solution for infusion
Novartis Investigative Site, Brussels
Novartis Investigative Site, Nordbyhagen
Novartis Investigative Site, Edegem
Novartis Investigative Site, Bonheiden
Novartis Investigative Site, Leuven
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Adelaide
Novartis Investigative Site, Perth
Novartis Investigative Site, Bellinzona
Novartis Investigative Site, Sankt Gallen
Novartis Investigative Site, Taipei
NYU Clinical Cancer Center, New York
Novartis Investigative Site, Taipei
Novartis Investigative Site, Marseille
Novartis Investigative Site, Berlin
Novartis Investigative Site, Santiago de Compostela
Novartis Investigative Site, Milan
Novartis Investigative Site, Milan
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Besançon
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Advent Health Cancer Institute, Orlando
Novartis Investigative Site, Taoyuan District
Novartis Investigative Site, Montpellier
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Izmir
Novartis Investigative Site, Verona
Novartis Investigative Site, Nantes
Novartis Investigative Site, Bochum
Novartis Investigative Site, Essen
Fort Wayne Medical Oncology Hematology Inc, Fort Wayne
Novartis Investigative Site, Florence
Novartis Investigative Site, Ramat Gan
Novartis Investigative Site, Thessaloniki
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Lyon 08
Highlands Oncology Group, Fayetteville
Novartis Investigative Site, Nový Jičín
Novartis Investigative Site, Paris
US Oncology Research Dallas, Dallas
Houston Methodist Hospital, Houston
Novartis Investigative Site, Bratislava
Novartis Investigative Site, Avignon
Huntsman Cancer Institute, Salt Lake City
Novartis Investigative Site, Ulm
University of California LA, Los Angeles
Novartis Investigative Site, Créteil
Seattle Cancer Care Alliance, Seattle
Novartis Investigative Site, Beijing
Novartis Investigative Site, Beijing
Novartis Investigative Site, Beijing
Novartis Investigative Site, Dalian
Novartis Investigative Site, Harbin
Novartis Investigative Site, Singapore
Novartis Investigative Site, Pushkin Saint Petersburg
Novartis Investigative Site, Shanghai
Novartis Investigative Site, Shanghai
Novartis Investigative Site, Shanghai
Novartis Investigative Site, Shanghai
Novartis Investigative Site, Nanjing
Novartis Investigative Site, Jining
Novartis Investigative Site, Tianjin
Novartis Investigative Site, Hangzhou
Novartis Investigative Site, Guangzhou
Novartis Investigative Site, Chengdu
Novartis Investigative Site, Omsk
Novartis Investigative Site, Xian
Novartis Investigative Site, Tel Aviv
Novartis Investigative Site, Jerusalem
Novartis Investigative Site, Brasília
Novartis Investigative Site, Ijuí
Novartis Investigative Site, Porto Alegre
Novartis Investigative Site, São Paulo
Novartis Investigative Site, Brampton
Novartis Investigative Site, Cambridge
Novartis Investigative Site, Toronto
Novartis Investigative Site, Brno
Novartis Investigative Site, Hradec Králové
Novartis Investigative Site, Prague
Novartis Investigative Site, Helsinki
Novartis Investigative Site, Tampere
Novartis Investigative Site, Nice
Novartis Investigative Site, Halle S
Novartis Investigative Site, Thessaloniki
Novartis Investigative Site, Budapest
Novartis Investigative Site, Budapest
Novartis Investigative Site, Nagoya
Novartis Investigative Site, Kashiwa
Novartis Investigative Site, Yokohama
Novartis Investigative Site, Osaka
Novartis Investigative Site, Chuo Ku
Novartis Investigative Site, Koto Ku
Novartis Investigative Site, Utrecht
Novartis Investigative Site, Oslo
Novartis Investigative Site, Banská Bystrica
Novartis Investigative Site, Košice
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Barcelona
Novartis Investigative Site, L'Hospitalet de Llobregat
Novartis Investigative Site, Malmo
Novartis Investigative Site, Umeå
Novartis Investigative Site, Geneva
Novartis Investigative Site, Adana
Novartis Investigative Site, Ankara
Novartis Investigative Site, Sutton
Novartis Investigative Site, Cambridge
Novartis Investigative Site, Liverpool
Novartis Investigative Site, London
Novartis Investigative Site, Oxford
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY